This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Masarykova Univerzita. Active years: 2018-2022.
Company Filing History:
Years Active: 2018-2022
Title: Vaclav Nemec: Innovator in Pharmaceutical Chemistry
Introduction
Vaclav Nemec is a notable inventor based in Brno-Bohunice, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for the treatment of various cancers. With a total of 2 patents, his work is recognized for its potential impact on medical treatments.
Latest Patents
Nemec's latest patents include innovative compounds such as 4-(1H-imidazol-5-yl)-1H-pyrrolo[2,3-b]pyridines, which are designed for use in the treatment of leukaemias, lymphomas, and solid tumors. This novel class of compounds shows promise in addressing serious health conditions. Another significant patent involves furopyridines as inhibitors of protein kinases. This invention relates to furo[3,2-b]pyridines that are substituted at least in position 5, which serve as inhibitors, regulators, or modulators, with applications in treating diseases like cancer and neurodegenerative disorders.
Career Highlights
Vaclav Nemec is affiliated with Masaryk University, where he continues to engage in research and development in pharmaceutical sciences. His academic background and ongoing research contribute to advancements in medical treatments.
Collaborations
Nemec has collaborated with notable colleagues such as Kamil Paruch and Vitezslav Bryja, enhancing the scope and impact of his research through teamwork and shared expertise.
Conclusion
Vaclav Nemec's contributions to pharmaceutical chemistry, particularly through his innovative patents, highlight his role as a key inventor in the field. His work continues to pave the way for new treatments in oncology and beyond.